SC134-deruxtecan, a fucosyl-GM1 targeting ADC for small cell lung cancer therapy
Abstract Background Small cell lung cancer (SCLC) remains a difficult disease to treat with poor long-term survival rates. New therapies offer modest overall survival benefit beyond that of chemotherapy alone, necessitating the development of improved therapies. Fucosyl-GM1 (FucGM1) is a glycolipid...
Saved in:
| Main Authors: | Bryony Heath, Bubacarr G. Kaira, Dhruma Thakker, Omar J. Mohammed, Ruhul Choudhury, Foram Dave, Poonam Vaghela, Elena Dubinina, Tina Parsons, Lindy Durrant, Mireille Vankemmelbeke |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06940-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors
by: Kayla Bastian, et al.
Published: (2025-05-01) -
Roles of core fucosylation modification in immune system and diseases
by: Qiu Pan, et al.
Published: (2025-02-01) -
Fucosylation in digestive inflammatory diseases and cancers: From mechanical studies to clinical translation
by: Caihan Duan, et al.
Published: (2025-11-01) -
Advances in the study of core fucosylation in mammals
by: TIAN Yinping, et al.
Published: (2021-01-01) -
Structural Characterization and Anticoagulant Potential of <i>Colochirus quadrangularis</i> Fucosylated Glycosaminoglycan 5−12 Oligomers with Unusual Branches
by: Xuedong Zhang, et al.
Published: (2025-02-01)